| 000 | 01358nam a2200337Ia 4500 | ||
|---|---|---|---|
| 001 | ebr10654918 | ||
| 003 | CaPaEBR | ||
| 006 | m u | ||
| 007 | cr cn||||||||| | ||
| 008 | 120802s2012 nyua sb 001 0 eng d | ||
| 010 | _z 2012418415 | ||
| 020 | _z9781619423435 | ||
| 020 | _z9781619423459 (ebook) | ||
| 040 |
_aCaPaEBR _cCaPaEBR |
||
| 035 | _a(OCoLC)828140625 | ||
| 050 | 1 | 4 |
_aRM405.5 _b.I54 2012eb |
| 245 | 0 | 0 |
_aInfliximab _h[electronic resource] : _bpharmacology, uses and limitations / _cAntonio D. Medrano Acevedo and Montserrat Fajardo Gaitan, editors. |
| 260 |
_aNew York : _bNova Science Publishers, _cc2012. |
||
| 300 |
_axiv, 188 p. : _bill. |
||
| 490 | 0 | _aImmunology and immune system disorders | |
| 504 | _aIncludes bibliographical references and index. | ||
| 533 |
_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2013. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries. |
||
| 650 | 0 | _aAnti-inflammatory agents. | |
| 650 | 0 |
_aInfliximab _xTherapeutic use. |
|
| 650 | 0 | _aInfliximab. | |
| 655 | 7 |
_aElectronic books. _2local |
|
| 700 | 1 | _aFajardo Gaitan, Montserrat. | |
| 700 | 1 | _aMedrano Acevedo, Antonio D. | |
| 710 | 2 | _aebrary, Inc. | |
| 856 | 4 | 0 |
_uhttp://site.ebrary.com/lib/rucke/Doc?id=10654918 _zAn electronic book accessible through the World Wide Web; click to view |
| 999 |
_c76204 _d76204 |
||